Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.

OBJECTIVES Recurrent miscarriage (RM) is one of the most common obstetric complications. Numerous studies have suggested that genetic variants leading to an impaired balance between coagulation and fibrinolysis may contribute to elevated risk of pregnancy loss. The aim of the study was to investigate a possible association between angiotensin-converting enzyme (ACE, rs1799752) I/D and plasminogen activator inhibitor type 1 (PAI-1, rs1799768) 4G/5G polymorphisms with RM among Polish women. MATERIAL AND METHODS DNA was extracted from peripheral blood samples of 152 women with a history of ≥ 2 consecutive pregnancy losses before 22 weeks of gestation, and 180 healthy controls with at least 1 live birth at term and no history of pregnancy loss. Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) were used to identify the polymorphisms. RESULTS No statistically significant differences were found in genotype and allele frequencies of the studied polymorphisms. The most relevant difference between the study group and controls was found for the ID genotype distribution of the ACE gene (52.6 vs. 46.7%, OR = 1.27, p = 0.28). The analysis of genotype coexistence revealed a higher incidence of the combination of the ACE II and the PAI-1 4G/4G genotypes in the control group (10.0 vs.5.9% in control group; p = 0.17). CONCLUSIONS The obtained results suggest no apparent association between the ACE I/D, PAI-1 4G/5G polymorphisms and increased RM susceptibility in the analyzed Polish population.

[1]  A. Leszczyńska,et al.  Pharmacological modulation of fibrinolytic response — In vivo and in vitro studies , 2015, Pharmacological reports : PR.

[2]  D. Koya,et al.  The Relevance of the Renin-Angiotensin System in the Development of Drugs to Combat Preeclampsia , 2015, International journal of endocrinology.

[3]  Libin Chen,et al.  Meta-Analysis of the Association between Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Recurrent Pregnancy Loss , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[4]  Ming Lu,et al.  Association between Plasminogen Activator Inhibitor‐1 Gene Polymorphisms and Recurrent Pregnancy Loss: A Systematic Review and Meta‐Analysis , 2015, American journal of reproductive immunology.

[5]  A. Seremak-Mrozikiewicz,et al.  The contribution of Hind III C>G PAI-1 gene polymorphism in etiology of recurrent miscarriages. , 2015, Ginekologia polska.

[6]  S. K. Lee,et al.  The PAI‐1 4G/5G and ACE I/D Polymorphisms and Risk of Recurrent Pregnancy Loss: A Case–Control Study , 2014, American journal of reproductive immunology.

[7]  J. Connors,et al.  The Role of Thrombophilia in Pregnancy , 2013, Thrombosis.

[8]  Zengfang Wang,et al.  Significant association between angiotensin-converting enzyme gene insertion/deletion polymorphism and risk of recurrent miscarriage: a systematic review and meta-analysis. , 2013, Metabolism: clinical and experimental.

[9]  Z. Ulčová-Gallová,et al.  Recurrent Pregnancy Loss, Plasminogen Activator Inhibitor‐1 (‐675) 4G/5G Polymorphism and Antiphospholipid Antibodies in Czech Women , 2013, American journal of reproductive immunology.

[10]  R. Dart,et al.  Expression of the Renin-Angiotensin System in a Human Placental Cell Line , 2013, Clinical Medicine & Research.

[11]  P. Kuo,et al.  Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss , 2012, Thrombosis and Haemostasis.

[12]  R. Callister,et al.  The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? , 2011, Placenta.

[13]  Patrick D. Thornton,et al.  Coagulation in pregnancy. , 2010, Best practice & research. Clinical obstetrics & gynaecology.

[14]  B. Innes,et al.  Expression of AT1R, AT2R and AT4R and their roles in extravillous trophoblast invasion in the human. , 2010, Placenta.

[15]  E. Jassem,et al.  The Angiotensinogen AGT p.M235T Gene Polymorphism May Be Responsible for the Development of Severe Anaphylactic Reactions to Insect Venom Allergens , 2010, International Archives of Allergy and Immunology.

[16]  F. Sharif,et al.  Polymorphisms in NOS3, ACE and PAI-1 Genes and Risk of Spontaneous Recurrent Miscarriage in the Gaza Strip , 2010, Medical Principles and Practice.

[17]  Y. Xia,et al.  The functional role of the renin-angiotensin system in pregnancy and preeclampsia. , 2008, Placenta.

[18]  A. Słowik,et al.  II Genotype of the Angiotensin-Converting Enzyme Gene Increases the Risk for Subarachnoid Hemorrhage From Ruptured Aneurysm , 2004, Stroke.

[19]  C. Thaler,et al.  Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. , 2003, Human reproduction.

[20]  P. Reitsma,et al.  The 4G/5G Polymorphism in the Plasminogen Activator Inhibitor-1 Gene Is not Associated with Myocardial Infarction , 1999, Thrombosis and Haemostasis.

[21]  J. Connell,et al.  Mistyping of the human angiotensin-converting enzyme gene polymorphism: frequency, causes and possible methods to avoid errors in typing. , 1996, Journal of molecular endocrinology.

[22]  A. Henney,et al.  The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. , 1993, The Journal of biological chemistry.

[23]  M. Blombäck,et al.  Enhanced Thrombin Generation and Fibrinolytic Activity in Normal Pregnancy and the Puerperium , 1992, Obstetrics and gynecology.

[24]  B. Brenner Haemostatic changes in pregnancy. , 2004, Thrombosis research.

[25]  A. Balcerzyk,et al.  Carrier-state of D allele in ACE gene insertion/deletion polymorphism is associated with coronary artery disease, in contrast to the C677-->T transition in the MTHFR gene. , 2003, Acta biochimica Polonica.